Table 2 Current GABHS Resistance Rates
From: Genetic commonality of macrolide-resistant group A beta hemolytic streptococcus pharyngeal strains
Site A | Site B | |
|---|---|---|
Macrolide-Susceptible | 192/200 (96%) | 188/200 (94%) |
Macrolide-Intermediate | 1/200 (0.5%) | 3/200 (1.5%) |
Macrolide-Resistant | 7/200 (3.5%) | 9/200 (4.5%) |
Inducible Clindamycin Resistancea | 3/7 (42.9%) | 3/9 (33.3%) |